focus -WSS

focus

author：leisure time 2025-09-27 22:59:44 - browse：23116

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Medical schools are missing the mark on artificial intelligence

focus

WSS

Gene therapy’s promise and the high cost of hope

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

What is microchimerism and how does it affect maternal health?

Russian court extends detention of American musician

Infant mortality in U.S. rose last year for first time in decades: CDC

Kidney transplant patients stopped immunosuppressants in trial

focus

focus

knowledge

Affirmative action in medical school literally saved lives

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Walensky prepares to leave CDC — and Congress — behind

Coloradans with cystic fibrosis could lose access to Trikafta

Heart attack and stroke risk calculators need revising

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Gene therapy’s promise and the high cost of hope

knowledge

California Joshua trees severely burned in massive wildfire

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Eat, drink, but be wary — 4 foods that interact with medications

All of Us, NIH's precision medicine initiative, gets a big boost

What is microchimerism and how does it affect maternal health?

Pharma needs to include young adults in clinical research

leisure time

hotspot

focus

hotspot